Stay updated on Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.

Latest updates to the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision history shows the revision label updated from v3.6.2 to v3.6.3. This represents a minor version bump in the record history.SummaryDifference0.0%

- Check8 days agoChange DetectedThe record history now shows Revision: v3.6.2, replacing the previous v3.6.0.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe record history now shows the study is no longer looking for participants. The latest revision tag has advanced to v3.6.0, replacing the previous v3.5.5 reference.SummaryDifference0.2%

- Check30 days agoChange DetectedA new page revision (v3.5.5) was added to the history, replacing the previous revision (v3.5.4). This reflects an updated version of the page for version tracking rather than substantive changes to study content.SummaryDifference0.0%

- Check51 days agoChange DetectedA new revision entry, v3.5.4, was added to the history to replace the previous v3.5.3. This reflects an update to the page's revision record.SummaryDifference0.0%

- Check65 days agoChange DetectedThe record history now reflects a newer revision tag, updating from v3.5.2 to v3.5.3. This indicates an updated version of the study record history on the page.SummaryDifference0.0%

Stay in the know with updates to Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.